Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.
Press releases published on June 19, 2025

📈 Trauma Implants Market to Reach $15.2 Billion by 2031 Amid Rising Road Injuries and Aging Population
PORTLAND, OR, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- The global trauma implants market, valued at $8.4 billion in 2021, is projected to grow to $15.2 billion by 2031, expanding at a CAGR of 6.1%. This growth is primarily driven by a surge in …

Overnight Zoom Karaoke Marathon to Support Suicide Prevention, June 20
Good Karma Karaoke to Host Overnight Zoom Karaoke Marathon in Solidarity with Suicide Prevention Efforts NEW YORK, NY, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- In a powerful show of unity and support for mental health awareness, Good Karma …

Endoscopic Ultrasound (EUS) Market Poised for Steady Growth: Driven by Chronic Disease -Forecast- 2031
PORTLAND, OR, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- The global Endoscopic Ultrasound (EUS) Market is experiencing significant growth, driven by rising incidences of gastrointestinal disorders, increasing chronic diseases, and expanding …

From Screen to Support: Digital Tools for Managing Adult ADD
GULFPORT, LA, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- Managing adult Attention Deficit Disorder (ADD) extends far beyond the office visit. The increasing integration of digital tools in the clinical setting is shifting how patients and …

Diabetes Care Devices Market Size to Reach USD 91.95 Billion by 2030, Says Mordor Intelligence
The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices HYDERABAD, TELANGANA, INDIA, June 19, 2025 /EINPresswire.com/ -- The growing prevalence of diabetes globally is fueling consistent …

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use …